NEPHROFLOW Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nephroflow, and what generic alternatives are available?
Nephroflow is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in NEPHROFLOW is iodohippurate sodium i-123. Additional details are available on the iodohippurate sodium i-123 profile page.
Summary for NEPHROFLOW
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Patent Applications: | 79 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NEPHROFLOW at DailyMed |
US Patents and Regulatory Information for NEPHROFLOW
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | NEPHROFLOW | iodohippurate sodium i-123 | INJECTABLE;INJECTION | 018289-001 | Dec 28, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |